EDUCATION

Graduate School
  • Washington University , St. Louis , MO

Medical School

  • Washington University , St. Louis , MO

Fellowship

Research
  • Boston Children's Hospital , Boston , MA

Fellowship

Clinical
  • Northwick Park Hospital , London , U.K.

Internship

  • St. Louis Children's Hospital , St. Louis , MO

Graduate Degree

  • St. Louis Children's Hospital , St. Louis , MO

CERTIFICATIONS

  • American Board of Pediatrics, Pediatric Rheumatology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Ringold S, Nigrovic PA, Feldman BM, Tomlinson GA, von Scheven E, Wallace CA, Huber AM, Schanberg LE, Li SC, Weiss PF, Fuhlbrigge RC, Morgan EM, Kimura Y. The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases. Arthritis Rheumatol. 2018 May; 70(5):669-678. View abstract
  2. Park CO, Fu X, Jiang X, Pan Y, Teague JE, Collins N, Tian T, O'Malley JT, Emerson RO, Kim JH, Jung Y, Watanabe R, Fuhlbrigge RC, Carbone FR, Gebhardt T, Clark RA, Lin CP, Kupper TS. Staged development of long-lived T-cell receptor aß TH17 resident memory T-cell population to Candida albicans after skin infection. J Allergy Clin Immunol. 2017 Nov 09. View abstract
  3. Tian T, Jin MQ, Dubin K, King SL, Hoetzenecker W, Murphy GF, Chen CA, Kupper TS, Fuhlbrigge RC. IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection. J Immunol. 2017 06 01; 198(11):4341-4351. View abstract
  4. Pan Y, Tian T, Park CO, Lofftus SY, Mei S, Liu X, Luo C, O'Malley JT, Gehad A, Teague JE, Divito SJ, Fuhlbrigge R, Puigserver P, Krueger JG, Hotamisligil GS, Clark RA, Kupper TS. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature. 2017 03 09; 543(7644):252-256. View abstract
  5. Batu ED, Kara Eroglu F, Tsoukas P, Hausmann JS, Bilginer Y, Kenna MA, Licameli GR, Fuhlbrigge RC, Özen S, Dedeoglu F. Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas. Arthritis Care Res (Hoboken). 2016 Dec; 68(12):1859-1865. View abstract
  6. Yoon J, Leyva-Castillo JM, Wang G, Galand C, Oyoshi MK, Kumar L, Hoff S, He R, Chervonsky A, Oppenheim JJ, Kuchroo VK, van den Brink MR, Malefyt Rde W, Tessier PA, Fuhlbrigge R, Rosenstiel P, Terhorst C, Murphy G, Geha RS. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. J Exp Med. 2016 Sep 19; 213(10):2147-66. View abstract
  7. Henderson LA, Volpi S, Frugoni F, Janssen E, Kim S, Sundel RP, Dedeoglu F, Lo MS, Hazen MM, Beth Son M, Mathieu R, Zurakowski D, Yu N, Lebedeva T, Fuhlbrigge RC, Walter JE, Nee Lee Y, Nigrovic PA, Notarangelo LD. Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2016 07; 68(7):1758-68. View abstract
  8. Bohr AH, Fuhlbrigge RC, Pedersen FK, de Ferranti SD, Müller K. Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures. Pediatr Rheumatol Online J. 2016 Jan 06; 14(1):3. View abstract
  9. Bhela S, Kempsell C, Manohar M, Dominguez-Villar M, Griffin R, Bhatt P, Kivisakk-Webb P, Fuhlbrigge R, Kupper T, Weiner H, Baecher-Allan C. Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. J Immunol. 2015 Mar 01; 194(5):2180-9. View abstract
  10. Sackstein R, Fuhlbrigge R. Western blot analysis of adhesive interactions under fluid shear conditions: the blot rolling assay. Methods Mol Biol. 2015; 1312:399-410. View abstract
  11. Freeman S, Bhatt A, Pedamallu C, King S, Duke F, Jung J, Lawton M, Anderson E, Fuhlbrigge RC, Kenna M, Licameli G, Meyerson M, Dedeoglu F. A121: in search of infectious triggers of periodic Fever, aphthous stomatitis, pharyngitis and adenitis syndrome. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S158. View abstract
  12. Henderson LA, Volpi S, Frugoni F, Kim S, Janssen E, Sundel RP, Dedeoglu F, Lo MS, Hazen MM, Mathieu R, Fuhlbrigge RC, Lee YN, Nigrovic PA, Notarangelo LD. A119: deep sequencing analysis of the T regulatory and T effector repertoire in juvenile idiopathic arthritis. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S156. View abstract
  13. Wu EY, Li SC, Torok KS, Virkud Y, Fuhlbrigge R, Rabinovich CE. A28: Description of the Juvenile Localized Scleroderma Subgroup of the CARRA Registry. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S43-4. View abstract
  14. Henderson LA, King SL, Ameri S, Martin SD, Simmons BP, Nigrovic PA, Fuhlbrigge RC. A161: Novel 3-Dimensional Explant Method Facilitates the Study of Lymphocyte Populations in the Synovium and Reveals a Large Population of Resident Memory T cells in Rheumatoid Arthritis. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S209. View abstract
  15. Vander Lugt B, Tubo NJ, Nizza ST, Boes M, Malissen B, Fuhlbrigge RC, Kupper TS, Campbell JJ. CCR7 plays no appreciable role in trafficking of central memory CD4 T cells to lymph nodes. J Immunol. 2013 Sep 15; 191(6):3119-27. View abstract
  16. Kentsis A, Shulman A, Ahmed S, Brennan E, Monuteaux MC, Lee YH, Lipsett S, Paulo JA, Dedeoglu F, Fuhlbrigge R, Bachur R, Bradwin G, Arditi M, Sundel RP, Newburger JW, Steen H, Kim S. Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease. EMBO Mol Med. 2013 Feb; 5(2):210-20. View abstract
  17. Ercan A, Barnes MG, Hazen M, Tory H, Henderson L, Dedeoglu F, Fuhlbrigge RC, Grom A, Holm IA, Kellogg M, Kim S, Adamczyk B, Rudd PM, Son MB, Sundel RP, Foell D, Glass DN, Thompson SD, Nigrovic PA. Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. Arthritis Rheum. 2012 Sep; 64(9):3025-33. View abstract
  18. Chang DK, Sui J, Geng S, Muvaffak A, Bai M, Fuhlbrigge RC, Lo A, Yammanuru A, Hubbard L, Sheehan J, Campbell JJ, Zhu Q, Kupper TS, Marasco WA. Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells. Mol Cancer Ther. 2012 Nov; 11(11):2451-61. View abstract
  19. Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, Rabinovich CE, Laxer RM, Higgins GC, Ferguson PJ, Lasky A, Baszis K, Becker M, Campillo S, Cartwright V, Cidon M, Inman CJ, Jerath R, O'Neil KM, Vora S, Zeft A, Wallace CA, Ilowite NT, Fuhlbrigge RC. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken). 2012 Aug; 64(8):1175-85. View abstract
  20. Purwar R, Schlapbach C, Xiao S, Kang HS, Elyaman W, Jiang X, Jetten AM, Khoury SJ, Fuhlbrigge RC, Kuchroo VK, Clark RA, Kupper TS. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med. 2012 Aug; 18(8):1248-53. View abstract
  21. Wang JX, Bair AM, King SL, Shnayder R, Huang YF, Shieh CC, Soberman RJ, Fuhlbrigge RC, Nigrovic PA. Ly6G ligation blocks recruitment of neutrophils via a ß2-integrin-dependent mechanism. Blood. 2012 Aug 16; 120(7):1489-98. View abstract
  22. Jiang X, Clark RA, Liu L, Wagers AJ, Fuhlbrigge RC, Kupper TS. Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature. 2012 Feb 29; 483(7388):227-31. View abstract
  23. Tian T, Dubin K, Jin Q, Qureshi A, King SL, Liu L, Jiang X, Murphy GF, Kupper TS, Fuhlbrigge RC. Disruption of TNF-a/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection. J Invest Dermatol. 2012 May; 132(5):1425-34. View abstract
  24. Peiser M, Tralau T, Heidler J, Api AM, Arts JH, Basketter DA, English J, Diepgen TL, Fuhlbrigge RC, Gaspari AA, Johansen JD, Karlberg AT, Kimber I, Lepoittevin JP, Liebsch M, Maibach HI, Martin SF, Merk HF, Platzek T, Rustemeyer T, Schnuch A, Vandebriel RJ, White IR, Luch A. Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci. 2012 Mar; 69(5):763-81. View abstract
  25. Merzaban JS, Burdick MM, Gadhoum SZ, Dagia NM, Chu JT, Fuhlbrigge RC, Sackstein R. Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells. Blood. 2011 Aug 18; 118(7):1774-83. View abstract
  26. Vander Lugt B, Beck ZT, Fuhlbrigge RC, Hacohen N, Campbell JJ, Boes M. TGF-ß suppresses ß-catenin-dependent tolerogenic activation program in dendritic cells. PLoS One. 2011; 6(5):e20099. View abstract
  27. Fuhlbrigge RC, Chaiban R. The immune system, the skin, and childhood rheumatic disease. Curr Rheumatol Rep. 2011 Apr; 13(2):103-9. View abstract
  28. Koduru S, Kumar L, Massaad MJ, Ramesh N, Le Bras S, Ozcan E, Oyoshi MK, Kaku M, Fujiwara Y, Kremer L, King S, Fuhlbrigge R, Rodig S, Sage P, Carman C, Alcaide P, Luscinskas FW, Geha RS. Cdc42 interacting protein 4 (CIP4) is essential for integrin-dependent T-cell trafficking. Proc Natl Acad Sci U S A. 2010 Sep 14; 107(37):16252-6. View abstract
  29. Yamanaka K, Fuhlbrigge RC, Mizutani H, Kupper TS. Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma. Arch Dermatol Res. 2010 Aug; 302(6):453-9. View abstract
  30. Ozen S, Fuhlbrigge RC. Update in paediatric vasculitis. Best Pract Res Clin Rheumatol. 2009 Oct; 23(5):679-88. View abstract
  31. Clark RA, Fuhlbrigge RC. Immunology and skin disease 2009: frontiers in cutaneous immunology. J Invest Dermatol. 2009 Aug; 129(8):1849-51. View abstract
  32. Kim S, El-Hallak M, Dedeoglu F, Zurakowski D, Fuhlbrigge RC, Sundel RP. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment. Arthritis Rheum. 2009 Jun; 60(6):1825-1830. View abstract
  33. Bianchi T, Pincus LB, Wurbel MA, Rich BE, Kupper TS, Fuhlbrigge RC, Boes M. Maintenance of peripheral tolerance through controlled tissue homing of antigen-specific T cells in K14-mOVA mice. J Immunol. 2009 Apr 15; 182(8):4665-74. View abstract
  34. Sackstein R, Fuhlbrigge R. Western blot analysis of adhesive interactions under fluid shear conditions: the blot rolling assay. Methods Mol Biol. 2009; 536:343-54. View abstract
  35. Tian T, Liu L, Freyschmidt EJ, Murphy GF, Kupper TS, Fuhlbrigge RC. Overexpression of IL-1alpha in skin differentially modulates the immune response to scarification with vaccinia virus. J Invest Dermatol. 2009 Jan; 129(1):70-8. View abstract
  36. Ota S, Cron RQ, Schanberg LE, O'Neil K, Mellins ED, Fuhlbrigge RC, Feldman BM. Research priorities in pediatric rheumatology: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus. Pediatr Rheumatol Online J. 2008 Apr 01; 6:5. View abstract
  37. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH, Frank MH. Identification of cells initiating human melanomas. Nature. 2008 Jan 17; 451(7176):345-9. View abstract
  38. Yamanaka K, Dimitroff CJ, Fuhlbrigge RC, Kakeda M, Kurokawa I, Mizutani H, Kupper TS. Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression. J Allergy Clin Immunol. 2008 Jan; 121(1):148-157.e3. View abstract
  39. Clark RA, Fuhlbrigge RC. Meeting report of immunology and skin disease: new perspectives. J Invest Dermatol. 2007 Aug; 127(8):1838-41. View abstract
  40. Weishaupt C, Munoz KN, Buzney E, Kupper TS, Fuhlbrigge RC. T-cell distribution and adhesion receptor expression in metastatic melanoma. Clin Cancer Res. 2007 May 01; 13(9):2549-56. View abstract
  41. El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. J Pediatr. 2007 Apr; 150(4):376-82. View abstract
  42. Fuhlbrigge RC, Weishaupt C. Adhesion molecules in cutaneous immunity. Semin Immunopathol. 2007 Apr; 29(1):45-57. View abstract
  43. Alcaide P, King SL, Dimitroff CJ, Lim YC, Fuhlbrigge RC, Luscinskas FW. The 130-kDa glycoform of CD43 functions as an E-selectin ligand for activated Th1 cells in vitro and in delayed-type hypersensitivity reactions in vivo. J Invest Dermatol. 2007 Aug; 127(8):1964-72. View abstract
  44. El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. J Pediatrics. 2007; 150:376-82. View abstract
  45. Weishaupt, C, KN Munoz, E Buzney, TS Kupper, and RC Fuhlbrigge. Dysregulation of vascular adhesion molecules in metastatic melanoma. Clinical Cancer Research. 2007; 13(9):2549-56. View abstract
  46. Tian T, L Liu, E-J Freyschmidt, G Murphy, TS Kupper and RC Fuhlbrigge. Modulation of Immune Response to Vaccinia Virus Scarification in K14/IL-1á Transgenic Mice. Journal of Virology. 2007; Submitted. View abstract
  47. Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol. 2006 Oct 01; 177(7):4488-94. View abstract
  48. Liu L, Fuhlbrigge RC, Karibian K, Tian T, Kupper TS. Dynamic programming of CD8+ T cell trafficking after live viral immunization. Immunity. 2006 Sep; 25(3):511-20. View abstract
  49. Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, Kim HJ, Brewer C, Zalewski C, Wiggs E, Hill S, Turner ML, Karp BI, Aksentijevich I, Pucino F, Penzak SR, Haverkamp MH, Stein L, Adams BS, Moore TL, Fuhlbrigge RC, Shaham B, Jarvis JN, O'Neil K, Vehe RK, Beitz LO, Gardner G, Hannan WP, Warren RW, Horn W, Cole JL, Paul SM, Hawkins PN, Pham TH, Snyder C, Wesley RA, Hoffmann SC, Holland SM, Butman JA, Kastner DL. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med. 2006 Aug 10; 355(6):581-92. View abstract
  50. Sackstein R, Fuhlbrigge R. The blot rolling assay: a method for identifying adhesion molecules mediating binding under shear conditions. Methods Mol Biol. 2006; 341:217-26. View abstract
  51. Goldbach-Mansky, R., N. Dailey, S. Canna, A. Gelabert, J. Jones, B. Rubin, J. Kim, C. Brewer, C. Zalewski, E. Wiggs, S. Hill, M. Turner, B. Karp, I. Aksentijevich, F. Pucino, S. Penzak , M. Haverkamp, L. Stein, B.S. Adams, T.L. Moore, R. Fuhlbrigge, B. Shaham, J. Jarvis, R. Vehe, L. Beitz, G. Gardner, W. Hannan, R. Warren, W. Horn, J.L. Cole, S. Paul, P. Hawkins, T. Hang Pham, C. Snyder, J. Butman, S. Hoffman, S.M. Holland, and D.L. Kastner. Neonatal Onset Multisystem Inflammatory Disease––A Disorder of Interleukin 1 Signaling Responsive to Anakinra. New England Journal of Medicine. 2006; 355(6):581-92. View abstract
  52. Fuhlbrigge, R.C., S.L. King, R. Sackstein, and T.S. Kupper. CD43 is a Ligand for E-selectin on Human Skin Homing T Cells. ePub Nov 2005. Blood. 2006; 107:1421-6. View abstract
  53. Liu L., RC Fuhlbrigge, K Karibian, T Tian, TS Kupper. 2006. . Dynamic programming of CD8+ T cell trafficking after live viral immunization. Immunity 25(3):511-20. 2006; 25(3):511-20. View abstract
  54. Hirahara, K., L. Liu, R.A. Clark, K. Yamanaka, R.C. Fuhlbrigge, and T.S. Kupper. The Majority of Human Peripheral Blood CD4+CD25highFoxp3+ Regulatory T Cells Bear Functional Skin-Homing Receptors. Journal of Immunology. 2006; 177:4488-4494. View abstract
  55. Fuhlbrigge RC, King SL, Sackstein R, Kupper TS. CD43 is a ligand for E-selectin on CLA+ human T cells. Blood. 2006 Feb 15; 107(4):1421-6. View abstract
  56. Gallego MD, de la Fuente MA, Anton IM, Snapper S, Fuhlbrigge R, Geha RS. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha. Int Immunol. 2006 Feb; 18(2):221-32. View abstract
  57. Binstadt BA, Levine JC, Nigrovic PA, Gauvreau K, Dedeoglu F, Fuhlbrigge RC, Weindling SN, Newburger JW, Sundel RP. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics. 2005 Jul; 116(1):e89-93. View abstract
  58. Liu L, Xu Z, Fuhlbrigge RC, Peña-Cruz V, Lieberman J, Kupper TS. Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. J Virol. 2005 Jun; 79(12):7363-70. View abstract
  59. Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol. 2004 Mar; 4(3):211-22. View abstract
  60. Chong BF, Murphy JE, Kupper TS, Fuhlbrigge RC. E-selectin, thymus- and activation-regulated chemokine/CCL17, and intercellular adhesion molecule-1 are constitutively coexpressed in dermal microvessels: a foundation for a cutaneous immunosurveillance system. J Immunol. 2004 Feb 01; 172(3):1575-81. View abstract
  61. Chong, B.F., J.E. Murphy, T.S. Kupper, R.C. Fuhlbrigge . E-selectin, TARC/CCL17 and ICAM-1 are constitutively co-expressed in dermal microvessels: a foundation for a cutaneous immunosurveillance mechanism. Journal of Immunology. 2004; 172:1575-1581. View abstract
  62. Binstadt BA, Caldas AM, Turvey SE, Stone KD, Weinstein HJ, Jackson J, Fuhlbrigge RC, Sundel RP. Rituximab therapy for multisystem autoimmune diseases in pediatric patients. J Pediatr. 2003 Nov; 143(5):598-604. View abstract
  63. Nigrovic PA, Fuhlbrigge RC, Sundel RP. Raynaud's phenomenon in children: a retrospective review of 123 patients. Pediatrics. 2003 Apr; 111(4 Pt 1):715-21. View abstract
  64. Binstadt, B.A., A.M.C. Caldas, S.E., Turvey, H.J. Weinstein, J. M. Jackson, R.C. Fuhlbrigge and R.P. Sundel . Rituximab Therapy for Mulstisystem Autoimmune Disease in Pediatric Patients. Journal of Pediatrics. 2003; 143(5):598-604. View abstract
  65. Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, Kupper TS. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol. 2002 Dec; 119(6):1405-10. View abstract
  66. Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol. 2002 Oct; 47(4):505-11. View abstract
  67. Fuhlbrigge RC, King SL, Dimitroff CJ, Kupper TS, Sackstein R. Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots. J Immunol. 2002 Jun 01; 168(11):5645-51. View abstract
  68. Pendl GG, Robert C, Steinert M, Thanos R, Eytner R, Borges E, Wild MK, Lowe JB, Fuhlbrigge RC, Kupper TS, Vestweber D, Grabbe S. Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1. Blood. 2002 Feb 01; 99(3):946-56. View abstract
  69. Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, Kupper TS . Increased CCR4 Expression in Cutaneous T Cell Lymphom. A. J Invest Dermatol. 2002; 119(6):1405-10. View abstract
  70. Fuhlbrigge, R.C., S.L. King, C.J. Dimitroff and R. Sackstein. . Direct, Real-time Observation of E- and P- Selectin Mediated Rolling on Cutaneous Lymphocyte-Associated Antigen Immobilized on Western Blots. Journal of Immunology. 2002; 168:5645-5651. View abstract
  71. Armerding D, Fuhlbrigge RC, Kieffer JD, Kupper TS. Tonsillar B cells do not express PSGL-1, but a significant fraction displays the cutaneous lymphocyte antigen and exhibits effective E- and P-selectin ligand activity. Int Arch Allergy Immunol. 2001 Sep; 126(1):78-90. View abstract
  72. Kieffer JD, Fuhlbrigge RC, Armerding D, Robert C, Ferenczi K, Camphausen RT, Kupper TS. Neutrophils, monocytes, and dendritic cells express the same specialized form of PSGL-1 as do skin-homing memory T cells: cutaneous lymphocyte antigen. Biochem Biophys Res Commun. 2001 Jul 20; 285(3):577-87. View abstract
  73. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol. 2001 Jun 11; 153(6):1277-86. View abstract
  74. Dimitroff, C.J., J.Y. Lee, S. Rafii, R.C. Fuhlbrigge and R. Sackstein . CD44 is a major E-Selectin Ligand on Human Hemotpoetic Progenitor Cells. Journal of Cell Biology. 2001; 153(6):1277-86. View abstract
  75. Artlett, C.M., F.W. Miller, L.G. Rider, et al. for the Childhood Myositis Heterogeneity Collaborative Study Group. . Persistent maternally-derived peripheral michrochimerism is associated with the juvenile idiopathic inflammatory myopathies. Rheumatology. 2001; 40:1279-84. View abstract
  76. Dimitroff CJ, Lee JY, Fuhlbrigge RC, Sackstein R. A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc Natl Acad Sci U S A. 2000 Dec 05; 97(25):13841-6. View abstract
  77. Eberhard BA, Sundel RP, Newburger JW, Baker A, Fuhlbrigge RC, Burns JC, Gellis SE. Psoriatic eruption in Kawasaki disease. J Pediatr. 2000 Oct; 137(4):578-80. View abstract
  78. Robert, C. Fuhlbrigge, M.D., Ph.D. Apparatus and Methods for Identifying Ligands. 2000. View abstract
  79. Carcamo AS, Fuhlbrigge RC, Hong R, Gullans SR, Kupper TS. Comparative analysis of the global transcriptional profile of human skin-homing memory T lymphocytes vs. non-skin homing memory and naive T lymphocytes J Invest Dermatol. 2000 Aug; 115(2):332. View abstract
  80. Fuhlbrigge, R.C. and T.S. Kupper. . Molecular mechanisms of allergic skin responses. Allergic Skin Diseases. Editors: Leung and Greaves. 2000; 29-51. View abstract
  81. Dimitroff, C.J., J. Lee, R.C. Fuhlbrigge and R. Sackstein. . A Distinct Glycoform of CD44 is an L-selectin Ligand on Human Hematopoietic Progenitor Cells. Proceedings of the National Academy of Sciences (USA). 2000; 97(25):13,814 - 13,13846. View abstract
  82. Carcamo, A.S., R.C. Fuhlbrigge, R. Hong, S.R. Gullans and T.S.; Kupper. . Comparative analysis of the global transcriptional profile of human skin-homing memory T lymphocytes vs. non-skin homing memory and naive T lymphocytes. Journal of Investigative Dermatology. 2000; 115(2):332. View abstract
  83. Robert C, Fuhlbrigge RC, Kieffer JD, Ayehunie S, Hynes RO, Cheng G, Grabbe S, von Andrian UH, Kupper TS. Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance. J Exp Med. 1999 Feb 15; 189(4):627-36. View abstract
  84. Alon R, Chen S, Fuhlbrigge R, Puri KD, Springer TA. The kinetics and shear threshold of transient and rolling interactions of L-selectin with its ligand on leukocytes. Proc Natl Acad Sci U S A. 1998 Sep 29; 95(20):11631-6. View abstract
  85. Clark RA, Fuhlbrigge RC, Springer TA. L-Selectin ligands that are O-glycoprotease resistant and distinct from MECA-79 antigen are sufficient for tethering and rolling of lymphocytes on human high endothelial venules. J Cell Biol. 1998 Feb 09; 140(3):721-31. View abstract
  86. Fuhlbrigge, RC, D. Samler and R.P. Sundel. . Aggressive Management of Juvenile Dermatomyositis (JDMS) Prevents Calcinosis. Proceedings of Park City IV: Pediatric Rheumatology Into The Next Century. 1998. View abstract
  87. Clark, R.A., R.C. Fuhlbrigge and T.A. Springer. . L-selectin ligands that are O-glycoprotease-resistant and distinct from MECA-79 antigen are sufficient for tethering and rolling of lymphocytes on human high endothelial venules. Journal of Cell Biology. 1998; 140 (3):721-731. View abstract
  88. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature. 1997 Oct 30; 389(6654):978-81. View abstract
  89. Kitayama J, Fuhlbrigge RC, Puri KD, Springer TA. P-selectin, L-selectin, and alpha 4 integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions. J Immunol. 1997 Oct 15; 159(8):3929-39. View abstract
  90. Chen S, Alon R, Fuhlbrigge RC, Springer TA. Rolling and transient tethering of leukocytes on antibodies reveal specializations of selectins. Proc Natl Acad Sci U S A. 1997 Apr 01; 94(7):3172-7. View abstract
  91. 16. Kitayama, J., R.C. Fuhlbrigge, K.D. Puri, and T.A. Springer. . P-selectin, L-selectin, and alpha(4) integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions. 1997; Journal of Immunology:159. View abstract
  92. Chen, S., R. Alon, R.C. Fuhlbrigge and T.A. Springer. . Rolling and transient tethering of leukocytes on antibodies reveal specialization of selectins. Proceedings of the National Academy of Science USA. 1997; 94:3172-3177. View abstract
  93. Alon R, Fuhlbrigge RC, Finger EB, Springer TA. Interactions through L-selectin between leukocytes and adherent leukocytes nucleate rolling adhesions on selectins and VCAM-1 in shear flow. J Cell Biol. 1996 Nov; 135(3):849-65. View abstract
  94. Fuhlbrigge RC, Alon R, Puri KD, Lowe JB, Springer TA. Sialylated, fucosylated ligands for L-selectin expressed on leukocytes mediate tethering and rolling adhesions in physiologic flow conditions. J Cell Biol. 1996 Nov; 135(3):837-48. View abstract
  95. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) J Exp Med. 1996 Sep 01; 184(3):1101-9. View abstract
  96. Alon R., R.C. Fuhlbrigge and T.A. Springer. . Leukocyte ligands for L-selectin nucleate rolling adhesions on vascular selectins and VCAM-1. Journal of Cell Biology. 1996; 135(3):849-865. View abstract
  97. Bleuel, C.C., R.C. Fuhlbrigge, J.M. Casasnovas, A. Aiuti and T.A. Springer. . A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). Journal of Experimental Medicine. 1996; 184:1101-1109. View abstract
  98. Alon R, Feizi T, Yuen CT, Fuhlbrigge RC, Springer TA. Glycolipid ligands for selectins support leukocyte tethering and rolling under physiologic flow conditions. J Immunol. 1995 May 15; 154(10):5356-66. View abstract
  99. Alon, R., T. Feizi, C.-T. Yuen, R.C. Fuhlbrigge and T.A. Springer. . Glycolipid ligands for selectins support leukocyte tethering and rolling adhesions under physiologic flow conditions. Journal of Immunology. 1995; 154(10):5356-5366 . View abstract
  100. Hawrylowicz CM, Duncan LM, Fuhlbrigge RC, Unanue ER. Regulation of antigen presentation. II. Anti-Ig and IL-2 induce IL-1 production by murine splenic B cells. J Immunol. 1989 May 15; 142(10):3361-8. View abstract
  101. Fuhlbrigge RC, Hogquist KA, Unanue ER, Chaplin DD. Molecular biology and genetics of interleukin-1. Year Immunol. 1989; 5:21-37. View abstract
  102. Hawrylowicz, C.M., L.M. Duncan, R.C. Fuhlbrigge and E.R. Unanue . Regulation of antigen presentation II: Anti-Ig and IL-2 induce IL-1 production by murine splenic B cells. Journal of Immunology. 1989; 142(10):3361-3368. View abstract
  103. Fuhlbrigge RC, Sheehan KC, Schreiber RD, Chaplin DD, Unanue ER. Monoclonal antibodies to murine IL-1 alpha. Production, characterization, and inhibition of membrane-associated IL-1 activity. J Immunol. 1988 Oct 15; 141(8):2643-50. View abstract
  104. Fuhlbrigge RC, Fine SM, Unanue ER, Chaplin DD. Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. Proc Natl Acad Sci U S A. 1988 Aug; 85(15):5649-53. View abstract
  105. Fuhlbrigge, R.C., K.C.F. Sheehan, R.D. Schreiber, D.D. Chaplin, and E.R. Unanue. Monoclonal antibodies to murine IL-1Ą: Production, characterization and inhibition of membrane-associated IL-1 activity. Journal of Immunology. 1988; 141(8):2643-2650. View abstract
  106. Chaplin, D.D., R.C. Fuhlbrigge, S. Jadidi, K.C.F. Sheehan, R.D. Schreiber, P.W. Gray, E.R. Unanue, and P. D'Eustachio. Restriction length polymorphism and linkage of murine IL-1 ƒÑ and ƒÒ genes on chromosome 2. In, Progress in Leukocyte Biology, Vol. 8,. "Monokines and other Non-lymphocytic Cytokines," Editors: M.C. Powanda, J.J. Oppenheim, M.J. Kluger, and C.A. Dinarello. 1988; 41-46. View abstract
  107. Fuhlbrigge, R.C., K.C.F. Sheehan, R.D. Schreiber, D.D. Chaplin, and E.R. Unanue. Monoclonal antibodies to murine IL-1Ą: Production, characterization and inhibition of membrane-associated IL-1 activity. Journal of Immunology. 1988; 141(8):2643-2650.. View abstract
  108. Fuhlbrigge, R.C., K.A. Hogquist, E.R. Unanue, and D.D. Chaplin. 1989. . Molecular biology and genetics of interleukin-1. Editors: J.M. Cruise and R.E. Lewis Jr.(Karger, Basel). The Year in Immunology 1988. 1988; 5:21-37. View abstract
  109. Fuhlbrigge RC, Chaplin DD, Kiely JM, Unanue ER. Regulation of interleukin 1 gene expression by adherence and lipopolysaccharide. J Immunol. 1987 Jun 01; 138(11):3799-802. View abstract
  110. Unanue ER, Weaver CT, Fuhlbrigge RC, Kiely JM, Chaplin DD. Membrane IL-1: a key protein in antigen presentation. Ann Inst Pasteur Immunol. 1987 May-Jun; 138(3):489-92. View abstract
  111. D'Eustachio P, Jadidi S, Fuhlbrigge RC, Gray PW, Chaplin DD. Interleukin-1 alpha and beta genes: linkage on chromosome 2 in the mouse. Immunogenetics. 1987; 26(6):339-43. View abstract
  112. Robert C. Fuhlbrigge, MD, Ph.D. Membrane Interleukin-1 [dissertation]. 1987. View abstract
  113. D'Eustachio, P., S. Jadidi, R.C. Fuhlbrigge, P.W. Gray, and D.D. Chaplin. Interleukin-1ƒÑ and ƒÒ genes: Linkage on chromosome 2 in the mouse. Immunogenetic. 1987; 26(6):339-343. View abstract
  114. Edwards BS, Fuhlbrigge RC, Borden EC. Separation of human natural killer cell subpopulations differentially responsive to interferon potentiation. J Interferon Res. 1986 Aug; 6(4):361-72. View abstract
  115. Edwards BS, Merritt JA, Fuhlbrigge RC, Borden EC. Low doses of interferon alpha result in more effective clinical natural killer cell activation. J Clin Invest. 1985 Jun; 75(6):1908-13. View abstract
  116. Fuhlbrigge RC, Edwards BS, Borden EC. Effects of interferon alpha on the sheep erythrocyte "receptor" of human lymphocytes. J Interferon Res. 1984; 4(4):499-505. View abstract